The longitudinal monitoring task is more likely to serve as sensitive secondary or exploratory endpoints, or even primary endpoints, in drug and device clinical trials, particularly for capturing subtle symptom changes and continuous symptom fluctuations, and assessing real-world quality of life [171, 181, 190]
Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases
DNp73, a dominant-negative variant of the tumor suppressor p73, enhances EMT and cancer stemness by abrogating the inhibitory effect of EPLIN on IGF-IR and downregulating miR-885-5p thereby increasing its direct target IGF-IR [74, 75]
Zhang SG
Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P